<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>13</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">V Ghislain</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Symposium NGS 2016 - Benchmarking trial and EQA NGS in (hemato-)oncology (EN)</style></title><secondary-title><style face="normal" font="default" size="100%">Symposium NGS 2016</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Next-generation sequencing (NGS)</style></keyword><keyword><style  face="normal" font="default" size="100%">NGS</style></keyword><keyword><style  face="normal" font="default" size="100%">oncology</style></keyword><keyword><style  face="normal" font="default" size="100%">personalized medicine</style></keyword><keyword><style  face="normal" font="default" size="100%">treatment</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2016</style></date></pub-dates></dates><publisher><style face="normal" font="default" size="100%">Sciensano</style></publisher><pub-location><style face="normal" font="default" size="100%">Brussels, Belgium</style></pub-location><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;Benchmarking trial and EQA NGS in (hemato-)oncology.&lt;br&gt;
• Examine the ability of the validated/accredited NGS assays to accurately and reproducibly detect clinically relevant mutations (solid tumors) in each of the participating laboratories&lt;br&gt;
• Compare the performance of different NGS methods currently used (art. 33bis) by different laboratories in Belgium&lt;br&gt;
• Develop a national EQA program : same standard!&lt;/p&gt;

&lt;p&gt;&amp;nbsp;&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">ISP WIV</style></issue></record></records></xml>